American Academy of Neurology
1080 Montreal Avenue
St. Paul
Minnesota
55116
United States
Tel: 651-695-1940
Fax: 651-695-2791
Website: http://www.aan.com/
Email: web@aan.com
300 articles about American Academy of Neurology
-
People with Essential Tremor May Have Increased Risk of Dementia
3/6/2024
Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released March 6, 2024.
-
Sleep Apnea Symptoms Linked to Memory and Thinking Problems
3/4/2024
People who experience sleep apnea may be more likely to also have memory or thinking problems, according to a preliminary study released March 3, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
-
New Study Finds Link Between Health Care Disparities and Stroke Treatment
2/29/2024
For people with stroke, social factors such as education, neighborhood and employment may be linked to whether they receive treatment with clot-busting drugs, according to a preliminary study released February 28, 2024, that will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
-
New Guidance Issued on the Determination of Brain Death AAN, AAP, CNS and SCCM Develop Consensus Practice Guideline
10/12/2023
New guidance has been issued for clinicians on the determination of brain death, also known as death by neurologic criteria.
-
Black People Less Likely to Receive Dementia-Related Medications
2/27/2023
Black people are receiving medications for dementia less often than white people, according to a preliminary study released February 26, 2023, that will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
-
Study Finds Air Pollution Exposure Linked to Parkinson's Risk, Identifies U.S. Hot Spot
2/24/2023
Living in areas of the United States with higher levels of air pollution is associated with an increased risk of Parkinson's disease, according to a preliminary study released February 23, 2023, that will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
-
Can the Lingering Effects of a Mild Case of COVID-19 Change Your Brain
2/20/2023
People with long COVID who experience anxiety and depression months after a mild case of COVID-19 may have brain changes that affect the function and structure of the brain, according to a preliminary study released February 20, 2023, that will be presented at the American Academy of Neurology's 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
-
How Healthy Is Your Brain? Improving Nation's Brain Health Is Focus of New AAN Plan
9/15/2022
Improving brain health at every stage of life, from a person's earliest years of development to their oldest years, is the focus of a new national effort by the American Academy of Neurology, the world's largest association of neurologists and neuroscience professionals.
-
The American Academy of Neurology Annual Meeting (AAN) was held virtually and in-person in Seattle from April 2-7. Here’s a look at some of the highlights.
-
Experimental Drug Linked to Reduced Tics in Children, Teens with Tourette Syndrome
3/30/2022
According to a new preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called ecopipam may have improved scores on tests of tic severity three months later.
-
Study: Brain Implant Safe, May Help Those with Paralysis Use Computer for Daily Tasks
3/29/2022
An investigational device called a brain-computer interface has been found safe in a small study of people with paralysis from ALS, and has allowed participants to use a computer to communicate by text and do daily tasks such as online shopping and banking, according to a preliminary study released, March 29, 2022, that will be presented at the American Academy of Neurology's 74th Annual Meeting being held in person in Seattle, April 2 to 7, 2022 and virtually, April 24 to 26, 2022.
-
Ketogenic Diet May Reduce Disability, Improve Quality of Life in People with MS
3/1/2022
A ketogenic diet, which primarily consists of foods like meat, fish, eggs, heavy cream, butter, oils and non-starchy vegetables like pea pods, carrots, broccoli and peppers, may be safe for people with multiple sclerosis.
-
AAN Issues Guideline for Treatment of Early Parkinson's Disease
11/15/2021
The American Academy of Neurology has issued a guideline providing recommendations for treating movement symptoms, called motor symptoms, in people with early Parkinson's disease.
-
Half of Kids with Inflammatory Syndrome After COVID-19 Have Neurologic Symptoms
4/17/2021
Half of the children who developed the serious condition associated with COVID-19 called multisystem inflammatory syndrome in children had neurologic symptoms or signs when they entered the hospital, according to preliminary research that will be presented at the American Academy of Neurology's 73rd Annual Meeting being held virtually April 17 to 22, 2021.
-
How Common Is Stroke in People Critically Ill with COVID-19?
4/16/2021
A large, year-long study has found that among people with COVID-19 who were hospitalized in an intensive care unit, 2% experienced a stroke after they were admitted to the ICU.
-
UCB showcases new research at the 73rd American Academy of Neurology Annual Meeting to demonstrate broad neurology leadership and future portfolio
4/16/2021
UCB reinforces commitment to delivering increased patient value by presenting latest research findings in epilepsy, myasthenia gravis, and Parkinson's disease
-
Study: Black People May Respond Differently to Common MS Therapy than White People
4/16/2021
A preliminary study suggests that Black people who have autoimmune neurologic diseases, multiple sclerosis and neuromyelitis optica spectrum disorder, may respond differently than white people to a common therapy meant to modulate the immune system.
-
Evobrutinib is the First and Only BTK Inhibitor to Demonstrate Reduction of a Key Biomarker of Neuronal Damage and Inflammation in Patients with MS
4/16/2021
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, will present data from a Phase II placebo-controlled randomized trial at the 2021 American Academy of Neurology Annual Meeting showing that the investigational Bruton’s tyrosine kinase inhibitor evobrutinib significantly reduced blood neurofilament light chain levels, a key biomarker of neuronal damage and inflammation, in patients with multiple sclerosis.
-
New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio
4/8/2021
Evrysdi (risdiplam) 2-year FIREFISH Part 2 data show improvement in motor function in infants with Type 1 spinal muscular atrophy (SMA)
-
Do Epilepsy Medications Taken During Pregnancy Affect a Child's Development?
3/5/2021
Children born to women taking certain medications for epilepsy during pregnancy have no developmental delays at age three when compared to children of healthy women without epilepsy, according to a preliminary study released March 4, 2021, that will be presented at the American Academy of Neurology's 73rd Annual Meeting being held virtually April 17 to 22, 2021.